Lina Chakrabarti, Ph.D.
Principal Scientist, BioPharmaceutical Development, Astrazeneca
Lina Chakrabarti, Ph.D. is listed as Principal Scientist, BioPharmaceutical Development, Astrazeneca. Lina is scheduled to speak at BPI West 2027 on 17 March 2027.
Compiled from published conference agendas; not yet confirmed by Lina. Is this you? Claim this profile.
About
Dr. Lina Chakrabarti is an experienced biopharmaceutical development specialist at AstraZeneca, leading the planning and execution of initiatives to enhance the efficiency, predictability, and robustness of cell line development for biotherapeutic protein production. Dr. Chakrabarti is passionate about building scalable, compliant platforms that accelerate program timelines and improve manufacturability. Dr. Chakrabarti has authored and co-authored several peer-reviewed articles in this field.
Upcoming
BPI West 2027 16 March 2027 – 18 March 2027
- Accelerating Cell Line Development: Saving Time and Increasing Capacity Speaker · 17 March 2027